Perrigo New York Company Profile

✉ Email this page to a colleague

What is the competitive landscape for PERRIGO NEW YORK, and what generic and branded alternatives to PERRIGO NEW YORK drugs are available?

PERRIGO NEW YORK has twenty-two approved drugs.

Summary for Perrigo New York

US Patents:	0
Tradenames:	10
Ingredients:	10
NDAs:	22
Patent Litigation for Perrigo New York:	See patent lawsuits for Perrigo New York

Drugs and US Patents for Perrigo New York

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Perrigo New York	HYDROCORTISONE	hydrocortisone	OINTMENT;TOPICAL	084969-003	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Perrigo New York	BETAMETHASONE VALERATE	betamethasone valerate	OINTMENT;TOPICAL	071478-001	Dec 23, 1987		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Perrigo New York	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	CREAM;TOPICAL	086810-001	Mar 4, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.